Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Uscom Limited (AU:UCM)
ASX:UCM
Holding AU:UCM?
Track your performance easily
UCM Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week Range<AU$0.01 - AU$0.06
Previous CloseAU$0.03
Volume0.00
Average Volume (3M)57.00K
Market Cap
AU$8.02M
Enterprise ValueAU$4.62M
Total Cash (Recent Filing)AU$4.70M
Total Debt (Recent Filing)AU$1.31M
Price to Earnings (P/E)―
Beta-1.33
Next Earnings
Feb 19, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares OutstandingN/A
10 Day Avg. Volume12,319
30 Day Avg. Volume57,004
Standard Deviation0.47
R-Squared0.01
Alpha0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)3.56
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Uscom Limited News
PremiumCompany Announcements
Uscom Limited Reports Increased Cash Reserves Amid Optimistic Outlook
PremiumCompany Announcements
Uscom Limited Director Increases Stake with New Performance Rights
PremiumCompany Announcements
Uscom Limited Sets Agenda for 2024 AGM
PremiumCompany Announcements
Uscom Limited Schedules 2024 AGM for Key VotesPremiumCompany Announcements
USCOM Limited Announces New Securities IssuancePremiumCompany Announcements
Uscom Limited Emphasizes Ethical Governance
PremiumCompany Announcements
Uscom Limited Upholds Corporate Governance Standards
PremiumCompany Announcements
Uscom Limited: Revenue Up, Losses DownOptions Prices
Currently, No data available
---
Ownership Overview
UCM FAQ
What was Uscom Limited’s price range in the past 12 months?
Uscom Limited lowest share price was <AU$0.01 and its highest was AU$0.06 in the past 12 months.
What is Uscom Limited’s market cap?
Currently, no data Available
When is Uscom Limited’s upcoming earnings report date?
Uscom Limited’s upcoming earnings report date is Feb 19, 2025 which is in 58 days.
How were Uscom Limited’s earnings last quarter?
Uscom Limited released its earnings results on Aug 28, 2024. The company reported -AU$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.005.
Is Uscom Limited overvalued?
According to Wall Street analysts Uscom Limited’s price is currently Overvalued.
Does Uscom Limited pay dividends?
Uscom Limited does not currently pay dividends.
What is Uscom Limited’s EPS estimate?
Uscom Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Uscom Limited have?
Uscom Limited has 250,477,000 shares outstanding.
What happened to Uscom Limited’s price movement after its last earnings report?
Uscom Limited reported an EPS of -AU$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 100%.
Which hedge fund is a major shareholder of Uscom Limited?
Currently, no hedge funds are holding shares in AU:UCM
---
Uscom Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-21.95%
12-Months-Change
Fundamentals
Return on Equity
-67.97%
Trailing 12-Months
Asset Growth
-0.88%
Trailing 12-Months
Company Description
Uscom Limited
USCOM Ltd is engaged in the development, design, manufacture, and marketing of premium non-invasive cardiovascular and pulmonary medical devices. The company's geographical segment includes Australia, Asia, America, Europe, and Other regions. It generates maximum revenue from Asia. The company offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, SPIROSONIC, a pulmonary function testing device based on multi-path ultrasound technology and the VENTITEST and VENTITEST-S ultrasonic ventilator calibration devices for optimising respiratory device performance.
---
Technical Analysis
Cyclopharm Limited
―
Resonance Health Ltd
―
LBT Innovations Limited
―
Race Oncology Ltd.
―
---